Serum miR-22 may be a biomarker for papillary thyroid cancer

The present study aimed to examine whether serum microRNA (miR)-22 may be considered a potential biomarker to differentiate patients with papillary thyroid cancer (PTC) from healthy controls. Reverse transcription-quantitative polymerase chain reaction demonstrated that serum miR-22 expression was s...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Deping, Guo, Changxiu, Kong, Tingting, Mi, Guangxi, Li, Jiantao, Sun, Yuhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396224/
https://www.ncbi.nlm.nih.gov/pubmed/30867770
http://dx.doi.org/10.3892/ol.2019.10011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396224/
https://www.ncbi.nlm.nih.gov/pubmed/30867770
http://dx.doi.org/10.3892/ol.2019.10011

Ejemplares similares